China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline Bloomberg China’s Biotechs Were The Small-Cap Rising Stars In H1 2025 insights.citeline.com China’s Biotech Sector Surpasses EU in Innovation Sharecafe Watch Post-Hoc Live: Is China a threat or investment opportunity for the US? Endpoints News As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment STAT Source link
Read More »